Bone Biologics Corporation (BBLG)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -1377.596 | -797.287 | -482.308 | -638.993 | -11774.194 | -48.27 | -19.578 | -146.309 |
Return on Equity (%) | 293.804 | 82.819 | 52.136 | 33.47 | 14.28 | 45.272 | -23.718 | -202.169 |
Return on Invested Capital (%) | 1477.12 | 208.817 | 63.715 | 53.553 | 11.615 | 31.007 | -58.537 | -213.013 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.222 | -0.194 | -0.325 | -0.387 | -0.446 | 0.635 | 0.389 | 0.927 |
Earnings Per Share | -0.542 | -0.163 | -0.167 | -0.112 | -0.059 | -0.156 | -0.097 | -2.855 |
Cash Per Share | 0.016 | 0.016 | 0.036 | 0.001 | N/A | 0.645 | 0.493 | 0.966 |
Working Capital Per Share | -0.061 | -0.004 | -0.325 | -0.018 | -0.446 | 0.635 | 0.389 | 0.927 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.542 | -0.163 | -0.167 | -0.112 | -0.059 | -0.155 | -0.097 | -2.855 |
EBITDA Per Share | -0.542 | -0.163 | -0.167 | -0.112 | -0.059 | -0.155 | -0.097 | -2.855 |
Free Cash Flow Per Share | -0.542 | -0.163 | -0.167 | -0.112 | -0.059 | -0.156 | -0.097 | -2.855 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 38.83M | 43.28M | 26.45M | 30.68M | 30.68M | 10.35M | 15.3M | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 10.35M | 15.3M | N/A | 3.13M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 2.27M |
Price to Earnings Ratio | -0.25 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.74 |
Price to Book Ratio | 0.77 |
Dividend Yield | - |
Shares Outstanding | 1.8M |
Average Volume (1 week) | 183.76k |
Average Volume (1 Month) | 109.57k |
52 Week Change | -63.27% |
52 Week High | 10.56 |
52 Week Low | 0.80 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.